The direct-to-consumer (DTC) genetic testing market is poised for remarkable growth, with an estimated valuation of USD 1,645.5 million in 2023, up from USD 1,485.1 million in 2022. According to Future Market Insights, the market is expected to expand at a compound annual growth rate (CAGR) of 11.40% from 2023 to 2033, reaching an impressive USD 4,843.4 million by 2033.
The rising popularity of direct-to-consumer genetic testing can be attributed to significant technological advancements that have made genealogy testing more accessible and affordable to consumers. These advancements have revolutionized the way individuals can explore their genetic heritage, understand potential health risks, and make informed decisions about their well-being.
Direct-to-consumer genetic testing allows individuals to obtain genetic information without the need for a healthcare provider. This convenience, coupled with decreasing costs, has driven widespread adoption of DTC genetic tests. Consumers are increasingly interested in uncovering their ancestry, understanding genetic predispositions to certain health conditions, and gaining personalized insights into their genetic makeup.
Request Your Detailed – Report Sample
The anticipated growth of the global direct-to-consumer genetic testing market has several causes. Due to advancements in DNA sequencing and data analytics, as well as an increase in the price of genetic testing kits, genetic testing is becoming more accessible and user-friendly. Consumer knowledge of the benefits of proactive health management and personalized therapy is also driving demand for genetic data to inform lifestyle choices, illness prevention strategies, and healthcare decisions.
Competitive Landscape:
Some of the prominent players in the global market are-
- 23andMe
- Ancestry DNA
- Color Genomics, Inc.
- Genetic Technology (EasyDNA)
- Full Genomes Corporation, Inc.
- Helix OpCo LLC
- IDENTIGENE, LLC/ DNA Diagnostics Center
- Living DNA Ltd
- MyHeritage Ltd
- Prenetics Limited
- Family Tree DNA
- Interleukin Genetics/orig3n
- Counsyl/Myriad Genetics, Inc.
- Veritas Genetics
- Fulgent Genomics
Some of the recent industry developments in the global direct-to-consumer genetic testing market are:
- In January 2022, 23andMe Holding Co., a leading consumer genetics and research company, received FDA clearance for a genetic health risk report on a hereditary prostate cancer marker.
- In August 2021, Ancestry, a global leader in family history, announced that it has agreed to acquire Geneanet, a renowned French genealogy company. With over 30 billion records from more than 80 countries, Ancestry helps customers discover new details about their family stories and ancestors.
- In June 2023, Prenetics Global Limited, a leading genomics and precision oncology company, announced financial results for the first quarter ending March 31, 2023, along with recent business updates.
Customization Available: Here
Direct-to-Consumer Genetic Testing Market Outlook by Category
By Product:
- Pharmacogenetics Tests
- Carrier Screening Tests
- Genetic Health Risk (GHR) Tests
- Cancer Predisposition Tests
- Low-Risk General Wellness Tests
- Ancestry Tests
By Technology:
- Single Nucleotide Polymorphism Chip
- Whole Genome Sequencing
By Sample:
- Saliva
- Urine
- Blood
By Sales Channel:
- Institutional Sales
- Hospitals
- Specialty Clinics
- Diagnostic Laboratories
- Others
- Retail Sales
- Retail Pharmacies
- Online Sales
By Region:
- North America
- Latin America
- Western Europe
- Eastern Europe
- South Asia & Pacific
- East Asia
- Middle East and Africa
Gain to Comprehensive Market Analysis: Purchase Now to Access
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
